Patients regain weight and health risks after stopping GLP-1 drugs
Updated
Updated · Pharmacy Business · May 5
Patients regain weight and health risks after stopping GLP-1 drugs
11 articles · Updated · Pharmacy Business · May 5
A BMJ review of more than 37 studies found lost weight typically returns within 18 months, with relapse about four times greater than among people relying on diet and exercise.
The analysis said type 2 diabetes and cardiovascular risks also re-emerge after treatment stops, even though semaglutide-based drugs can help manage those conditions while patients remain on them.
Researchers from School of Clinical Medicine and Trinity College said obesity is a chronic, relapsing condition and urged healthy eating and regular exercise when pausing medication.
Are weight loss drugs a miracle cure or a lifelong medical crutch for a chronic disease?
Why do many patients keep weight off after stopping Ozempic, despite warnings of rapid regain?
Can a DNA test predict your success on weight loss drugs like Wegovy?